Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 776

2.

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW.

J Am Coll Cardiol. 2000 Mar 1;35(3):681-9.

4.

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S.

Circulation. 1996 Aug 15;94(4):690-7.

5.

Racial differences in the outcome of left ventricular dysfunction.

Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ.

N Engl J Med. 1999 Feb 25;340(8):609-16. Erratum in: N Engl J Med 1999 Jul 22;341(4):298.

6.

Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.

Dries DL, Strong MH, Cooper RS, Drazner MH.

J Am Coll Cardiol. 2002 Jul 17;40(2):311-7. Erratum in: J Am Coll Cardiol 2002 Sep 4;40(5):1019.

8.

The effect of gender on outcome in digitalis-treated heart failure patients.

Domanski M, Fleg J, Bristow M, Knox S.

J Card Fail. 2005 Mar;11(2):83-6.

PMID:
15732025
9.

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.

Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A.

Circulation. 2003 Jun 17;107(23):2926-31. Epub 2003 May 27.

10.

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG.

J Am Coll Cardiol. 1992 Sep;20(3):527-32.

PMID:
1512329
12.

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.

J Am Coll Cardiol. 1998 Feb;31(2):419-25.

13.
14.

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.

Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S.

Am J Cardiol. 1996 Oct 15;78(8):890-5.

PMID:
8888661
15.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ.

J Am Coll Cardiol. 2001 Aug;38(2):421-8.

16.

Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.

Suskin N, Sheth T, Negassa A, Yusuf S.

J Am Coll Cardiol. 2001 May;37(6):1677-82.

17.

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.

Alsheikh-Ali AA, Wang PJ, Rand W, Konstam MA, Homoud MK, Link MS, Estes NA 3rd, Salem DN, Al-Ahmad AM.

Am Heart J. 2004 Jun;147(6):1061-5.

PMID:
15199356
18.

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ.

Eur Heart J. 2000 Aug;21(15):1238-45.

PMID:
10924313
19.

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E; Studies of Left Ventricular Dysfunction.

J Am Coll Cardiol. 2003 Aug 20;42(4):705-8.

20.

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ.

Circulation. 1999 Sep 21;100(12):1311-5.

Supplemental Content

Support Center